MedTrace Logo

Brief Psychological Intervention to Reduce Alcohol Consumption

NCT07686276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2026-07-07

No results posted yet for this study

Summary

Continuous levels of hazardous alcohol consumption (i.e., 14 or more units per week) is one of the leading risk factors of ill health and early mortality, contributing to around 9,809 deaths a year in the UK. The aim of the present research is to test the effect of helping people to reward themselves when they have successfully reduced/abstained from their previous levels of alcohol consumption. Each participant will be randomly allocated to one of two conditions. The trial requires 128 participants to perform a fully powered statistical analysis. The two conditions include: (1) a control condition (asked to form a plan to reduce/abstain from alcohol consumption), or (2) a weekly self-incentivising condition (asked to reward themselves at the end of each week that they have successfully reduced/abstained their previous levels of alcohol consumption). The main outcome measure will be units of alcohol consumed/not consumed, which will be self-reported at 1-week and 1-month follow-up time points.

Conditions

  • Health Behavior

Interventions

BEHAVIORAL

Self-incentive

Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to specify a self-incentive on which they could implement at the end of each week which they have been successful.

BEHAVIORAL

Plan

Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to form their plan.

Sponsors & Collaborators

  • Lancaster University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-20
Primary Completion
2026-06-21
Completion
2026-06-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07686276 on ClinicalTrials.gov